vs
Cryoport, Inc.（CYRX）与Dominari Holdings Inc.（DOMH）财务数据对比。点击上方公司名可切换其他公司
Cryoport, Inc.的季度营收约是Dominari Holdings Inc.的1.5倍（$45.5M vs $30.1M），Cryoport, Inc.净利率更高（-17.5% vs -438.1%，领先420.6%），Dominari Holdings Inc.同比增速更快（220.4% vs 9.6%），过去两年Dominari Holdings Inc.的营收复合增速更高（369.1% vs 10.4%）
Cryoport Inc是一家面向生命科学、生物制药及细胞和基因治疗领域的全球专业温控物流与供应链解决方案供应商，合作客户包括研究机构、生物技术企业及制药厂商，为临床试验样本、先进疗法产品等敏感生物材料的安全运输提供支持。
CYRX vs DOMH — 直观对比
营收规模更大
CYRX
是对方的1.5倍
$30.1M
营收增速更快
DOMH
高出210.8%
9.6%
净利率更高
CYRX
高出420.6%
-438.1%
两年增速更快
DOMH
近两年复合增速
10.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.5M | $30.1M |
| 净利润 | $-8.0M | $-131.8M |
| 毛利率 | 47.8% | — |
| 营业利润率 | -17.0% | -8.9% |
| 净利率 | -17.5% | -438.1% |
| 营收同比 | 9.6% | 220.4% |
| 净利润同比 | 57.4% | -12426.2% |
| 每股收益（稀释后） | $-0.19 | $-6.94 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CYRXDOMH
| Q4 25 | $45.5M | $30.1M | ||
| Q3 25 | $44.2M | $50.8M | ||
| Q2 25 | $45.5M | $34.1M | ||
| Q1 25 | $41.0M | $8.1M | ||
| Q4 24 | $41.5M | $9.4M | ||
| Q3 24 | $38.3M | $4.0M | ||
| Q2 24 | $39.7M | $6.2M | ||
| Q1 24 | $37.3M | $1.4M |
净利润CYRXDOMH
| Q4 25 | $-8.0M | $-131.8M | ||
| Q3 25 | $-6.9M | $125.2M | ||
| Q2 25 | $105.2M | $16.6M | ||
| Q1 25 | $-12.0M | $-32.5M | ||
| Q4 24 | $-18.7M | $1.1M | ||
| Q3 24 | $805.0K | $-4.2M | ||
| Q2 24 | $-78.0M | $-6.1M | ||
| Q1 24 | $-18.9M | $-5.4M |
毛利率CYRXDOMH
| Q4 25 | 47.8% | — | ||
| Q3 25 | 48.2% | — | ||
| Q2 25 | 47.0% | — | ||
| Q1 25 | 45.4% | — | ||
| Q4 24 | 47.0% | — | ||
| Q3 24 | 45.5% | — | ||
| Q2 24 | 44.5% | — | ||
| Q1 24 | 40.4% | — |
营业利润率CYRXDOMH
| Q4 25 | -17.0% | -8.9% | ||
| Q3 25 | -22.5% | -3.1% | ||
| Q2 25 | -21.2% | -57.0% | ||
| Q1 25 | -23.1% | -394.6% | ||
| Q4 24 | -30.7% | 0.4% | ||
| Q3 24 | -34.9% | -79.1% | ||
| Q2 24 | -196.5% | -44.3% | ||
| Q1 24 | -46.9% | -205.2% |
净利率CYRXDOMH
| Q4 25 | -17.5% | -438.1% | ||
| Q3 25 | -15.7% | 246.4% | ||
| Q2 25 | 231.4% | 48.7% | ||
| Q1 25 | -29.2% | -400.5% | ||
| Q4 24 | -45.1% | 11.4% | ||
| Q3 24 | 2.1% | -104.2% | ||
| Q2 24 | -196.4% | -99.1% | ||
| Q1 24 | -50.7% | -398.0% |
每股收益（稀释后）CYRXDOMH
| Q4 25 | $-0.19 | $-6.94 | ||
| Q3 25 | $-0.18 | $7.27 | ||
| Q2 25 | $2.05 | $1.12 | ||
| Q1 25 | $-0.28 | $-3.02 | ||
| Q4 24 | $-0.42 | $0.21 | ||
| Q3 24 | $-0.02 | $-0.67 | ||
| Q2 24 | $-1.62 | $-1.01 | ||
| Q1 24 | $-0.43 | $-0.91 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $411.2M | $80.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $502.6M | $69.4M |
| 总资产 | $765.0M | $112.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CYRXDOMH
| Q4 25 | $411.2M | $80.5M | ||
| Q3 25 | $421.3M | $176.2M | ||
| Q2 25 | $426.0M | $28.2M | ||
| Q1 25 | $244.0M | $18.9M | ||
| Q4 24 | $250.6M | $8.2M | ||
| Q3 24 | $259.4M | $7.2M | ||
| Q2 24 | $414.9M | $12.1M | ||
| Q1 24 | $438.2M | $7.1M |
股东权益CYRXDOMH
| Q4 25 | $502.6M | $69.4M | ||
| Q3 25 | $513.3M | $210.2M | ||
| Q2 25 | $519.1M | $88.6M | ||
| Q1 25 | $398.8M | $42.4M | ||
| Q4 24 | $401.9M | $39.9M | ||
| Q3 24 | $418.6M | $38.3M | ||
| Q2 24 | $400.1M | $42.4M | ||
| Q1 24 | $472.2M | $47.7M |
总资产CYRXDOMH
| Q4 25 | $765.0M | $112.9M | ||
| Q3 25 | $774.3M | $223.4M | ||
| Q2 25 | $773.9M | $109.3M | ||
| Q1 25 | $699.8M | $52.3M | ||
| Q4 24 | $703.5M | $47.1M | ||
| Q3 24 | $701.8M | $43.4M | ||
| Q2 24 | $852.3M | $49.1M | ||
| Q1 24 | $942.8M | $52.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $919.0K | $22.7M |
| 自由现金流经营现金流 - 资本支出 | $-4.5M | — |
| 自由现金流率自由现金流/营收 | -10.0% | — |
| 资本支出强度资本支出/营收 | 12.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-25.0M | — |
8季度趋势，按日历期对齐
经营现金流CYRXDOMH
| Q4 25 | $919.0K | $22.7M | ||
| Q3 25 | $2.2M | $-4.9M | ||
| Q2 25 | $-7.3M | $-353.0K | ||
| Q1 25 | $-4.3M | $1.2M | ||
| Q4 24 | $-5.5M | $-16.7M | ||
| Q3 24 | $447.0K | $-4.7M | ||
| Q2 24 | $-8.0M | $1.4M | ||
| Q1 24 | $-3.3M | $-8.6M |
自由现金流CYRXDOMH
| Q4 25 | $-4.5M | — | ||
| Q3 25 | $-1.3M | — | ||
| Q2 25 | $-11.7M | — | ||
| Q1 25 | $-7.5M | — | ||
| Q4 24 | $-10.7M | — | ||
| Q3 24 | $-3.8M | — | ||
| Q2 24 | $-11.8M | — | ||
| Q1 24 | $-7.3M | — |
自由现金流率CYRXDOMH
| Q4 25 | -10.0% | — | ||
| Q3 25 | -2.9% | — | ||
| Q2 25 | -25.7% | — | ||
| Q1 25 | -18.3% | — | ||
| Q4 24 | -25.8% | — | ||
| Q3 24 | -9.9% | — | ||
| Q2 24 | -29.8% | — | ||
| Q1 24 | -19.5% | — |
资本支出强度CYRXDOMH
| Q4 25 | 12.0% | — | ||
| Q3 25 | 7.8% | — | ||
| Q2 25 | 9.6% | — | ||
| Q1 25 | 7.7% | — | ||
| Q4 24 | 12.6% | — | ||
| Q3 24 | 11.1% | — | ||
| Q2 24 | 9.5% | — | ||
| Q1 24 | 10.7% | — |
现金转化率CYRXDOMH
| Q4 25 | — | — | ||
| Q3 25 | — | -0.04× | ||
| Q2 25 | -0.07× | -0.02× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -15.65× | ||
| Q3 24 | 0.56× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CYRX
暂无分部数据
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
